{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:23Z","timestamp":1755216743964,"version":"3.43.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Asparaginase, a critical component of current pediatric acute leukemia treatment protocols, is associated with a number of serious side effects, one of which is pancreatitis. Pancreatitis can result in significant morbidity and mortality from necrosis, pseudocyst formation, hemorrhage, systemic inflammation, intestinal perforation, and sepsis. Another rare complication of pancreatitis is posterior reversible encephalopathy syndrome, likely mediated by systemic inflammation secondary to pancreatic autodigestion and proinflammatory cytokine-mediated vascular endothelial damage. Here, we review this association in the literature and report 2 pediatric patients with leukemia who developed posterior reversible encephalopathy syndrome in the setting of asparaginase-associated pancreatitis.<\/jats:p>","DOI":"10.1097\/mph.0000000000002367","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T10:17:26Z","timestamp":1640859446000},"page":"e709-e712","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Posterior Reversible Encephalopathy Syndrome in the Setting of Asparaginase-associated Pancreatitis in 2 Pediatric Patients With Acute Leukemia"],"prefix":"10.1097","volume":"44","author":[{"given":"Amanda","family":"Scheuermann","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology\/Blood and Marrow Transplantation, Department of Pediatrics Medical College of Wisconsin and Children\u2019s Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Harker-Murray","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology\/Blood and Marrow Transplantation, Department of Pediatrics Medical College of Wisconsin and Children\u2019s Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Pommert","sequence":"additional","affiliation":[{"name":"Division of Oncology, Cancer and Blood Diseases Institute, Cincinnati Children\u2019s Hospital Medical Center"},{"name":"Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,12,29]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","article-title":"Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia","volume":"23","author":"Pession","year":"2005","journal-title":"J Clin Oncol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM198609113151101","article-title":"Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia","volume":"315","author":"Clavell","year":"1986","journal-title":"N Engl J Med"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1040-8428(98)00015-8","article-title":"Use of L-asparaginase in childhood ALL","volume":"28","author":"Muller","year":"1998","journal-title":"Crit Rev Oncol Hematol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JCO.19.02208","article-title":"Asparaginase-associated pancreatitis in acute lymphoblastic leukemia: results from the NOPHO ALL2008 treatment of patients 1-45 years of age","volume":"38","author":"Rank","year":"2020","journal-title":"J Clin Oncol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(08)60107-5","article-title":"Acute pancreatitis","volume":"371","author":"Frossard","year":"2008","journal-title":"Lancet"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00004836-200301000-00016","article-title":"Issues in hyperlipidemic pancreatitis","volume":"36","author":"Yadav","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood.V89.6.1886","article-title":"Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia","volume":"89","author":"Parsons","year":"1997","journal-title":"Blood"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/bjh.12016","article-title":"Asparaginase-associated pancreatitis in children","volume":"159","author":"Raja","year":"2012","journal-title":"Br J Haematol"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1200\/JCO.2015.64.5812","article-title":"Clinical and genetic risk factors for acute pancreatitis in patients with acute lymphoblastic leukemia","volume":"34","author":"Liu","year":"2016","journal-title":"J Clin Oncol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/leu.2016.203","article-title":"Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol","volume":"31","author":"Wolthers","year":"2017","journal-title":"Leukemia"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","article-title":"Posterior reversible encephalopathy syndrome","volume":"264","author":"Fischer","year":"2017","journal-title":"J Neurol"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/CM9.0000000000000431","article-title":"Posterior reversible encephalopathy syndrome in a woman with pancreatitis","volume":"132","author":"Luo","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5414\/CN106976","article-title":"Recurrent posterior reversible encephalopathy syndrome in nephrotic syndrome: case report and review of the literature","volume":"78","author":"Yamada","year":"2012","journal-title":"Clin Nephrol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"e3758","DOI":"10.1097\/MD.0000000000003758","article-title":"Posterior reversible encephalopathy syndrome complicating traumatic pancreatitis: a pediatric case report","volume":"95","author":"Sigurta","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R15-20250804","first-page":"552","article-title":"Posterior reversible encephalopathy syndrome following acute pancreatitis during chemotherapy for acute monocytic leukemia","volume":"55","author":"Nishimoto","year":"2014","journal-title":"Rinsho Ketsueki"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2014-205072","article-title":"The challenges of antiphospholipid syndrome: experience from diagnosis to self-care","volume":"2014","author":"Larmour","year":"2014","journal-title":"BMJ Case Rep"},{"key":"R17-20250804","first-page":"2178","article-title":"Posterior reversible encephalopathy syndrome\u2014an underrecognized manifestation of systemic lupus erythematosus","volume":"33","author":"Kur","year":"2006","journal-title":"J Rheumatol"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/pcn.12033","article-title":"Acute alcohol withdrawal accompanied by posterior reversible encephalopathy syndrome","volume":"67","author":"Ishikawa","year":"2013","journal-title":"Psychiatry Clin Neurosci"},{"key":"R19-20250804","first-page":"5785413","article-title":"Peripartum severe acute pancreatitis with rare complications: case report and review of literature","volume":"2020","author":"Ali","year":"2020","journal-title":"Case Rep Surg"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"567","DOI":"10.20344\/amp.7368","article-title":"Acute pancreatitis and posterior reversible encephalopathy syndrome: a case report","volume":"29","author":"Magno Pereira","year":"2016","journal-title":"Acta Med Port"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.5811\/westjem.2015.8.28347","article-title":"Posterior reversible encephalopathy syndrome (PRES) after acute pancreatitis","volume":"16","author":"Murphy","year":"2015","journal-title":"West J Emerg Med"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.jhh.1001664","article-title":"Recurrent posterior reversible encephalopathy syndrome (PRES)","volume":"18","author":"Hagemann","year":"2004","journal-title":"J Hum Hypertens"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"192.e3","DOI":"10.1016\/j.genhosppsych.2014.12.004","article-title":"A case of posterior reversible encephalopathy syndrome associated with acute pancreatitis and chronic alcoholism","volume":"37","author":"Baek","year":"2015","journal-title":"Gen Hosp Psychiatry"},{"key":"R24-20250804","first-page":"177","article-title":"Acute intermittent porphyria presenting as acute pancreatitis and posterior reversible encephalopathy syndrome","volume":"17","author":"Shen","year":"2008","journal-title":"Acta Neurol Taiwan"},{"key":"R25-20250804","first-page":"1","article-title":"Posterior reversible encephalopathy syndrome (PRES) associated with acute pancreatitis","volume":"4","author":"Pinotti","year":"2018","journal-title":"Open J Clin Med Case Rep"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"e232228","DOI":"10.1136\/bcr-2019-232228","article-title":"Posterior reversible encephalopathy syndrome in acute pancreatitis: a rare stroke mimic","volume":"13","author":"Bonavia","year":"2020","journal-title":"BMJ Case Rep"},{"key":"R27-20250804","first-page":"1236","article-title":"Posterior reversible encephalopathy syndrome in acute pancreatitis","volume":"82","author":"Compagnone","year":"2016","journal-title":"Minerva Anestesiol"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","article-title":"Posterior reversible encephalopathy syndrome\u2014insight into pathogenesis, clinical variants and treatment approaches","volume":"14","author":"Granata","year":"2015","journal-title":"Autoimmun Rev"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate","year":"2015","journal-title":"Lancet Neurol"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.mehy.2014.02.022","article-title":"Posterior reversible encephalopathy syndrome: the endothelial hypotheses","volume":"82","author":"Marra","year":"2014","journal-title":"Med Hypotheses"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2017.06.044","article-title":"Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome","volume":"380","author":"Parikh","year":"2017","journal-title":"J Neurol Sci"},{"key":"R32-20250804","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.0000000000003510","article-title":"Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome","volume":"88","author":"Singhal","year":"2017","journal-title":"Neurology"},{"key":"R33-20250804","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1078155220941590","article-title":"Potential voriconazole associated posterior reversible leukoencephalopathy in children with malignancies: report of two cases","volume":"27","author":"Amanati","year":"2020","journal-title":"J Oncol Pharm Pract"},{"key":"R34-20250804","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00003246-199601000-00026","article-title":"Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation","volume":"24","author":"Bone","year":"1996","journal-title":"Crit Care Med"},{"key":"R35-20250804","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1164\/ajrccm.152.5.7582288","article-title":"Lymphatic release of cytokines during acute lung injury complicating severe pancreatitis","volume":"152","author":"Montravers","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"R36-20250804","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell","year":"1989","journal-title":"FEBS Lett"},{"key":"R37-20250804","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000018746","article-title":"Acute pancreatitis: the pathophysiological role of cytokines and integrins. New trends for treatment?","volume":"16","author":"Osman","year":"1999","journal-title":"Dig Surg"},{"key":"R38-20250804","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(98)00060-3","article-title":"Experimental acute pancreatitis results in increased blood-brain barrier permeability in the rat: a potential role for tumor necrosis factor and interleukin 6","volume":"242","author":"Farkas","year":"1998","journal-title":"Neurosci Lett"},{"key":"R39-20250804","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1182\/blood.V100.4.1334.h81602001334_1334_1339","article-title":"Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF","volume":"100","author":"Friedl","year":"2002","journal-title":"Blood"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:13:43Z","timestamp":1754338423000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,29]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002367","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2021,12,29]]},"assertion":[{"value":"2021-04-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}